Impact of extended ginsenoside Rb1 on early chronic kidney disease: a randomized, placebo-controlled study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of extended ginsenoside Rb1 on early chronic kidney disease: a randomized, placebo-controlled study

Published:2016-11-17 Issue:1 Volume:25 Page:33-40
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Xu Xuefang,Lu Qiandi,Wu Jingyue,Li Yixiang,Sun Jinzhu

Funder

Developing Medicine Funds

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/s10787-016-0296-x.pdf

Reference35 articles.

1. Bao HY et al (2005) Memory enhancing and neuroprotective effects of selected ginsenosides. Arch Pharm Res 28:335–342

2. Barton DL et al (2010) Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: nCCTG trial N03CA. Support Care Cancer 18:179–187. doi: 10.1007/s00520-009-0642-2

3. Chen J, Siriki R (2015) Antioxidants therapy for patients with chronic kidney disease: a question of balance. Am J Nephrol 42:318–319. doi: 10.1159/000441628

4. Coresh J et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047. doi: 10.1001/jama.298.17.2038

5. Fogo AB (2007) Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 22:2011–2022. doi: 10.1007/s00467-007-0524-0

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Red ginseng ameliorates lipotoxicity-induced renal fibrosis in hyperuricemia mice;Journal of Ethnopharmacology;2024-06

2. Multi-layered effects of Panax notoginseng on immune system;Pharmacological Research;2024-06

3. Ginsenoside – a promising natural active ingredient with steroidal hormone activity;Food & Function;2024

4. Antioxidants for adults with chronic kidney disease;Cochrane Database of Systematic Reviews;2023-11-02

5. Ginsenosides for therapeutically targeting inflammation through modulation of oxidative stress;International Immunopharmacology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3